Megan Townsend

Megan Townsend

Company: Illumina

Job title: Business Development Manager, CDx Partnerships

Seminars:

Interactive Panel Discussion & Q&A: Driving the Next Generation of Oncology Diagnostics & Therapeutics: We Cannot Do It Alone 7:15 pm

The latest biomarker and CDx strategies to guarantee broader patient adoption of oncology therapeutics across the globe How biopharma is integrating NGS into clinical development to achieve long-term strategic stability and clinical success in oncology therapeutic development How Illumina is working to bridge the different ecosystems across the cancer care continuum, from early innovation, clinical…Read more

day: Driving the Next Generation of Oncology Diagnostics & Therapeutics

Shaping the Future of Clinical Next Generation Sequencing Testing in Oncology 7:05 pm

Illumina’s CDx Vision: Building a single CGP/CDx solution for all market The path forward to evolve testing infrastructure and gain broad patient access Building strategic partnerships to evolve & grow a changing healthcare landscapeRead more

day: Driving the Next Generation of Oncology Diagnostics & Therapeutics

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.